Fundraising Fox
/Companies
Sign in

ChemT Biotechnology

Singapore, SG · 4 known investors

Find your way into ChemT Biotechnology

Sign up to see every warm intro you have to ChemT Biotechnology

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the ChemT Biotechnology team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

ChemT builds CelMo, an AI-driven virtual cell platform that models cell states and predicts responses to process, genetic, and molecular changes to optimize biomanufacturing. It applies this to CHO cells for antibody/protein production and T cell therapy manufacturing (including its Chemplify small molecule), serving biopharma teams working on cell line and process development.

AI & Machine LearningBiotechDeep Tech

Founders & leadership

LWLing Wu
Ling WuPresident & Co-FounderLing Wu previously served as a principal investigator at BeOne Medicines and spent several years at the National University of Singapore as a research fellow and senior research fellow, after completing a PhD there in 2020. He has also worked as a consulting lead at Biotech Connection Singapore and as a freelance writer for MyBioGate, and was named to the Prestige Singapore 40 under 40 list.
JSJie Sun
Jie SunCEO & Co-FounderShe previously co-founded basys.ai, a generative AI startup, and worked as a data scientist at Dana-Farber Cancer Institute and Mass General Hospital, with a master's degree in health data science from Harvard University and a bachelor's in statistics from the National University of Singapore.
PN
Prof. Nicholas GascoigneScientific Advisor & Co-Founder

Investors · 4

ACADEMY INVESTORlisted by ACADEMY INVESTORNew York

How we know: ACADEMY INVESTOR's portfolio page · Not right? Tell us

AIN Ventureslisted by AIN VenturesNew York · $500K – $1M

How we know: AIN Ventures's portfolio page · Not right? Tell us

Wavemaker Partnerslisted by Wavemaker PartnersSingapore · $100K – $2.5M

How we know: Wavemaker Partners's portfolio page · funding news · Not right? Tell us

Funding

SEC filings, press & company announcements

$9M disclosed across 2 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

In the news

ChemT Biotechnology Raises $4M in Seed Fundingfinsmes.com · Jun 2026ChemT Biotechnology Raises US$5 Million in 18 months to bring AI to Biomanufacturingprnewswire.com · Jun 2026

Frequently asked questions

What does ChemT Biotechnology do?
ChemT builds CelMo, an AI-driven virtual cell platform that models cell states and predicts responses to process, genetic, and molecular changes to optimize biomanufacturing. It applies this to CHO cells for antibody/protein production and T cell therapy manufacturing (including its Chemplify small molecule), serving biopharma teams working on cell line and process development.
Who founded ChemT Biotechnology?
ChemT Biotechnology was founded by Ling Wu, Jie Sun.
Who are ChemT Biotechnology's investors?
ChemT Biotechnology's investors include Draper University Ventures, ACADEMY INVESTOR, AIN Ventures, Wavemaker Partners.
How much funding has ChemT Biotechnology raised?
ChemT Biotechnology has disclosed $9M raised across 2 rounds.
Where is ChemT Biotechnology headquartered?
ChemT Biotechnology is headquartered in Singapore, SG.